Related Experiment Video
Updated: Dec 6, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
First reported case of a longevity overestimation error in the new Medtronic tablet-based device programmer
1Deborah Heart and Lung Center Lawrenceville NJ USA.
Journal of Arrhythmia
|October 7, 2020
Summary
New tablet-based systems for cardiac rhythm devices may overestimate battery life, potentially impacting patient care. This discrepancy highlights the need for careful validation of new technologies in pacemaker management.
Area of Science:
- Cardiology
- Medical Device Technology
- Digital Health
Background:
- Advancements in mobile technology are leading to miniaturized, tablet-based systems for cardiac rhythm device management.
- These systems are replacing traditional programmers, necessitating reliable data for clinical decision-making.
Observation:
- A case report identified a significant discrepancy in battery longevity estimations.
- This involved remote monitoring data, a conventional programmer, and the Medtronic CareLink SmartSync Device Manager.
Findings:
- The tablet-based SmartSync Device Manager erroneously overestimated pacemaker battery longevity.
- This occurred in a pacemaker-dependent patient who had reached Recommended Replacement Time (RRT).
Implications:
- Inaccurate battery longevity data can compromise patient safety and device management.
- Validation of new cardiac device management systems is crucial before widespread clinical adoption.
- Ensuring data consistency across different device programmers is essential for reliable patient care.

